BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 117668)

  • 1. Prolactin and somatotropin responses to TRH in schizophrenic patients.
    Posmurová M; Hainer V; Marek J; Filip V; Srámková J
    Act Nerv Super (Praha); 1979 Oct; 21(3):171-3. PubMed ID: 117668
    [No Abstract]   [Full Text] [Related]  

  • 2. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRH test in schizophrenic patients and controls.
    Roy A; Wolkowitz O; Doran A; Pickar D
    Biol Psychiatry; 1989 Feb; 25(4):523-6. PubMed ID: 2495030
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of thyrotropin-releasing hormone in chronic schizophrenic patients.
    Kobayashi K; Nakaoka K; Tsuji H; Shohmori T
    Acta Med Okayama; 1980 Sep; 34(4):263-73. PubMed ID: 6452029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal growth hormone response to TRH in chronic adolescent schizophrenic patients.
    Weizman R; Weizman A; Gil-Ad I; Tyano S; Laron Z
    Br J Psychiatry; 1982 Dec; 141():582-5. PubMed ID: 6819022
    [No Abstract]   [Full Text] [Related]  

  • 6. Decrease of plasma somatotropin levels following thyroliberin (TRH) administration in patients with hyperthyroidism.
    Pawlikowski M; Owczarczyk I
    Endokrinologie; 1979; 73(3):363-6. PubMed ID: 115673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine findings in the schizophrenias.
    Garver DL
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):103-9. PubMed ID: 2897906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin releasing hormone (TRH): a useful tool for psychoneuroendocrine investigation.
    Loosen PT; Prange AJ
    Psychoneuroendocrinology; 1980 Jan; 5(1):63-80. PubMed ID: 6771791
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
    Fujita M; Toyoda K; Motomura N; Kuroda K; Shimizu T
    Rinsho Shinkeigaku; 1985 Jul; 25(7):767-75. PubMed ID: 3935351
    [No Abstract]   [Full Text] [Related]  

  • 10. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
    Naber D; Ackenheil M; Laakmann G
    Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
    Cabranes JA; Fuentenebro F; Recio MN; Borque M; Almoguera MI
    Int Pharmacopsychiatry; 1982; 17(1):1-7. PubMed ID: 6123489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    Psychopharmacol Commun; 1975; 1(2):191-200. PubMed ID: 817373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
    Braddock LE; Blake IM
    Br J Psychiatry; 1981 Nov; 139():404-7. PubMed ID: 6120732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
    Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal growth hormone response to LRH and TRH in adolescent schizophrenic boys.
    Gil-Ad I; Dickerman Z; Weizman R; Weizman A; Tyano S; Laron Z
    Am J Psychiatry; 1981 Mar; 138(3):357-60. PubMed ID: 6781365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin, Growth hormone, thyrotropin, insulin, C-peptide, glucose tolerance and pituitary-gonadal axis in patients with compensated renal failure.
    Schernthaner G; Stummvoll HK; Ludwig H; Spona J
    Proc Eur Dial Transplant Assoc; 1979; 16():703-5. PubMed ID: 121463
    [No Abstract]   [Full Text] [Related]  

  • 20. A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
    Fujita M; Shimizu T
    Bull Osaka Med Sch; 1986 Oct; 32(2):73-84. PubMed ID: 3122863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.